Skip to main content

ABT - Abbott Laboratories

This page shows which of the focused investors we track hold ABT and how their positions changed, so you can see how much conviction the group has in the stock.

In Q3 2013 it was held by 11 managers with an aggregate reported value of $1.12B, which is 0.17% of the combined portfolio.

As of Q3 2013, 11 tracked institutional managers held ABT (Abbott Laboratories) with an aggregate reported value of $1.12B — 0.17% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades ABT — sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q3 2013
Ticker
ABT

13F data is delayed and excludes shorts/non-13F assets.

Holders

1Mason Hawkins - Southeastern Asset Management2.27%Reduce -4.8%13,727,856$455.63M
2Richard Pzena - Pzena Investment Management1.38%Add +49.2%6,449,283$214.05M
3Polen Capital Management - Polen Capital Management4.77%New6,244,148$207.24M
4Jensen Investment Management - Jensen Investment Management2.90%Add +1.3%5,652,243$187.6M
5Valley Forge Capital Management - Valley Forge Capital Management1.31%Add +8.2%598,301$19.86M
6Steven Check - Check Capital Management2.23%Add +150.8%412,098$13.68M
7Mairs & Power Growth Fund - Mairs & Power Growth Fund0.19%Add +4.3%338,861$11.25M
8Robert Olstein - Olstein Capital Management0.74%Add +12.4%145,000$4.81M
9Thomas Russo - Gardner Russo & Quinn0.03%Add +0.2%86,503$2.87M
10Bill Nygren - Oakmark Funds0.00%Reduce -5.4%44,178$1.47M
11Dodge & Cox - Dodge & Cox0.00%Reduce -0.8%36,930$1.23M
Loading holder history for ABT…